Showing results (261-270 of 1,934) with videos related to
Sort By:
Pageof 194
Virus Genes|January 1, 1997
Natural spillover of a distinctly Canidae-associated biotype of rabies virus into an expanded wildlife host range in southern AfricaL Nel, J Jacobs, J Jaftha, et al.The Journal of Cardiovascular Surgery|November 1, 1992
Profunda femoral artery pseudoaneurysm after percutaneous transluminal procedures manifested by neuropathyM J Jacobs, I D Gregoric, G J ReulJournal of Fish Biology|August 26, 2010
Effect of Flavobacterium columnare inoculation, antibiotic treatments and resident bacteria on rainbow trout Oncorhynchus mykiss eyed egg survival and external membrane structureM E Barnes, D Bergmann, J Jacobs, et al.Seminars in Thoracic and Cardiovascular Surgery|February 20, 1998
Spinal cord monitoring with myogenic motor evoked potentials: early detection of spinal cord ischemia as an integral part of spinal cord protective strategies during thoracoabdominal aneurysm surgeryP de Haan, C J Kalkman, M J JacobsOphthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|January 1, 1988
Assessment of contrast sensitivity of patients with macular disease using reduced contrast near visual acuity chartsA L Greeves, B L Cole, R J JacobsClinical Orthopaedics and Related Research|April 2, 2004
Mechanisms of failure of total hip replacements: lessons learned from retrieval studiesKazuo Hirakawa, Joshua J Jacobs, Robert Urban, et al.Applied Clinical Informatics|January 16, 2015
Assessment of readiness for clinical decision support to aid laboratory monitoring of immunosuppressive care at U.S. liver transplant centersJ Jacobs, C Weir, R S Evans, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|March 10, 2000
Maxillofacial hydatid cystsM M Bouckaert, E J Raubenheimer, F J JacobsThe Orthopedic Clinics of North America|October 1, 1993
Mechanisms of bone loss associated with total hip replacementJ J Jacobs, D R Sumner, J O GalanteAmerican Journal of Clinical Oncology|February 1, 1993
A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group StudyJ H Malfetano, J A Blessing, A J JacobsPageof 194